Methods for defining distinct bioenergetic profiles in platelets, lymphocytes, monocytes, and neutrophils, and the oxidative burst from human blood

Laboratory Investigation

Volumn 93, Issue 6, 2013, Pages 690-700

  Chacko, Balu K ^a   Kramer, Philip A ^a   Ravi, Saranya ^a   Johnson, Michelle S ^a   Hardy, Robert W ^a   Ballinger, Scott W ^a   Darley Usmar, Victor M ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

mitochondria; neutrophils; peripheral blood mononuclear cells; respiratory burst

Indexed keywords

PHORBOL 13 ACETATE 12 MYRISTATE;

ADULT; ARTICLE; BIOENERGY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE; MALE; MEASUREMENT; MITOCHONDRIAL RESPIRATION; MONOCYTE; NEUTROPHIL; NORMAL HUMAN; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RESPIRATORY BURST; RESPIRATORY CHAIN; THROMBOCYTE; VALIDATION PROCESS;

EID: 84878533006     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2013.53     Document Type: Article

References (50)

1. Srinivasan S, Yeh M, Danziger EC, et al. Glucose regulates monocyte adhesion through endothelial production of interleukin-8. Circ Res 2003;92:371-377.
2. Yamagishi SI, Edelstein D, Du XL, et al. Hyperglycemia potentiates collagen-induced platelet activation through mitochondrial superoxide overproduction. Diabetes 2001;50:1491-1494.
3. Avila C, Huang RJ, Stevens MV, et al. Platelet mitochondrial dysfunction is evident in type 2 diabetes in association with modifications of mitochondrial anti-oxidant stress proteins. Exp Clin Endocrinol Diabetes 2012;120:248-251.
4. Guo X, Wu J, Du J, et al. Platelets of type 2 diabetic patients are characterized by high ATP content and low mitochondrial membrane potential. Platelets 2009;20:588-593.
5. Mancuso M, Calsolaro V, Orsucci D, et al. Mitochondria, cognitive impairment, and Alzheimer's disease. Int J Alzheimers Dis 2009;2009, pii951548.
6. Shi P, Wei Y, Zhang J, et al. Mitochondrial dysfunction is a converging point of multiple pathological pathways in amyotrophic lateral sclerosis. J Alzheimer Dis 2010;20(Suppl 2):S311-S324.
7. Jin S. Autophagy, mitochondrial quality control, and oncogenesis. Autophagy 2006;2:80-84.
8. Lim KL, Ng XH, Grace LG, et al. Mitochondrial dynamics and Parkinson's disease: focus on parkin. Antioxid Redox Signal 2012; 16:935-949.
9. Hill BG, Benavides GA, Lancaster JR, et al. Integration of cellular bioenergetics with mitochondrial quality control and autophagy. Biol Chem 2012;393:1485-1512.
10. Perez-Pinzon MA, Stetler RA, Fiskum G. Novel mitochondrial targets for neuroprotection. J Cereb Blood Flow Metab 2012;32:1362-1376.
11. Chacko BK, Srivastava A, Johnson MS, et al. Mitochondria-targeted ubiquinone (MitoQ) decreases ethanol-dependent micro and macro hepatosteatosis. Hepatology 2011;54:153-163.
12. Chacko BK, Reily C, Srivastava A, et al. Prevention of diabetic nephropathy in Ins2 (AkitaJ) mice by the mitochondria-targeted therapy MitoQ. Biochem J 2010;432:9-19.
13. Smith RA, Murphy MP. Animal and human studies with the mitochondria-targeted antioxidant MitoQ. Ann N Y Acad Sci 2010; 1201:96-103.
14. Fink BD, Herlein JA, O'Malley Y, et al. Endothelial cell and platelet bioenergetics: effect of glucose and nutrient composition. PLoS One 2012;7:e39430.
15. Cordero MD, De Miguel M, Moreno Fernandez AM, et al. Mitochondrial dysfunction and mitophagy activation in blood mononuclear cells of fibromyalgia patients: implications in the pathogenesis of the disease. Arthritis Res Ther 2010;12:R17.
16. Japiassu AM, Santiago AP, d'Avila JC, et al. Bioenergetic failure of human peripheral blood monocytes in patients with septic shock is mediated by reduced F1Fo adenosine-5'-triphosphate synthase activity. Crit Care Med 2011;39:1056-1063.
17. Widlansky ME, Wang J, Shenouda SM, et al. Altered mitochondrial membrane potential, mass, and morphology in the mononuclear cells of humans with type 2 diabetes. Transl Res 2010;156:15-25.
18. Mosconi L, de Leon M, Murray J, et al. Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer's disease. J Alzheimer Dis 2011;27:483-490.
19. Shi C, Guo K, Yew DT, et al. Effects of ageing and Alzheimer's disease on mitochondrial function of human platelets. Exp Gerontol 2008;43:589-594.
20. Lenaz G, Bovina C, Castelluccio C, et al. Mitochondrial complex I defects in aging. Mol Cell Biochem 1997;174:329-333.
21. D'Aurelio M, Merlo Pich M, Catani L, et al. Decreased Pasteur effect in platelets of aged individuals. Mech Ageing Dev 2001;122:823-833.
22. Satoh N, Shimatsu A, Himeno A, et al. Unbalanced M1/M2 phenotype of peripheral blood monocytes in obese diabetic patients: effect of pioglitazone. Diabetes Care 2010;33:e7.
23. Nagy G, Koncz A, Fernandez D, et al. Nitric oxide, mitochondrial hyperpolarization, and T cell activation. Free Radic Biol Med 2007;42:1625-1631.
24. van der Windt GJ, Everts B, Chang CH, et al. Mitochondrial respiratory capacity is a critical regulator of CD8 T cell memory development. Immunity 2012;36:68-78.
25. Alvehus M, Buren J, Sjostrom M, et al. The human visceral fat depot has a unique inflammatory profile. Obesity 2010;18:879-883.
26. Estep JM, Baranova A, Hossain N, et al. Expression of cytokine signaling genes in morbidly obese patients with non-alcoholic steatohepatitis and hepatic fibrosis. Obes Surg 2009;19:617-624.
27. Slattery ML, Fitzpatrick FA. Convergence of hormones, inflammation, and energy-related factors: a novel pathway of cancer etiology. Cancer Prev Res 2009;2:922-930.
28. Rosa JS, Heydari S, Oliver SR, et al. Inflammatory cytokine profiles during exercise in obese, diabetic, and healthy children. J Clin Res Pediatr Endocrinol 2011;3:115-121.
29. Onyango I, Khan S, Miller B, et al. Mitochondrial genomic contribution to mitochondrial dysfunction in Alzheimer's disease. J Alzheimer Dis 2006;9:183-193.
30. Hand WL, Hand DL, Vasquez Y. Increased polymorphonuclear leukocyte respiratory burst function in type 2 diabetes. Diabetes Res Clin Pract 2007;76:44-50.
31. Omori K, Ohira T, Uchida Y, et al. Priming of neutrophil oxidative burst in diabetes requires preassembly of the NADPH oxidase. J Leukoc Biol 2008;84:292-301.
32. Zielinska-Przyjemska M, Olejnik A, Dobrowolska-Zachwieja A, et al. In vitro effects of beetroot juice and chips on oxidative metabolism and apoptosis in neutrophils from obese individuals. Phytother Res 2009;23:49-55.
33. Nieman DC, Nehlsen-Cannarella SL, Henson DA, et al. Immune response to exercise training and/or energy restriction in obese women. Med Sci Sports Exerc 1998;30:679-686.
34. Mossberg N, Andersen O, Nordin M, et al. Leukocyte oxygen radical production determines disease severity in the recurrent Guillain-Barre syndrome. J Inflamm (Lond) 2010;7:40.
35. Korzenik JR, Dieckgraefe BK. Is Crohn's disease an immunodeficiency? A hypothesis suggesting possible early events in the pathogenesis of Crohn's disease. Dig Dis Sci 2000;45:1121-1129.
36. Hultqvist M, Olofsson P, Holmberg J, et al. Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc Natl Acad Sci USA 2004;101:12646-12651.
37. Agudelo-Florez P, Costa-Carvalho BT, Lopez JA, et al. Association of glucose-6-phosphate dehydrogenase deficiency and X-linked chronic granulomatous disease in a child with anemia and recurrent infections. Am J Hematol 2004;75:151-156.
38. Rosa-Borges A, Sampaio MG, Condino-Neto A, et al. [Glucose-6- phosphate dehydrogenase deficiency with recurrent infections: case report]. J Pediatr (Rio J) 2001;77:331-336.
39. Winkelstein JA, Marino MC, Johnston Jr. RB, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 2000;79:155-169.
40. Richardson MP, Ayliffe MJ, Helbert M, et al. A simple flow cytometry assay using dihydrorhodamine for the measurement of the neutrophil respiratory burst in whole blood: comparison with the quantitative nitrobluetetrazolium test. J Immunol Methods 1998; 219:187-193.
41. Matzner Y. Neutrophil function studies in clinical medicine. Transfus Med Rev 1987;1:171-181.
42. Walkowiak B, Kesy A, Michalec L. Microplate reader - a convenient tool in studies of blood coagulation. Thrombosis Res 1997;87:95-103.
43. Dranka BP, Benavides GA, Diers AR, et al. Assessing bioenergetic function in response to oxidative stress by metabolic profiling. Free Radic Biol Med 2011;51:1621-1635.
44. Chen Y, Junger WG. Measurement of oxidative burst in neutrophils. Methods Mol Biol 2012;844:115-124.
45. Hill BG, Dranka BP, Zou L, et al. Importance of the bioenergetic reserve capacity in response to cardiomyocyte stress induced by 4- hydroxynonenal. Biochem J 2009;424:99-107.
46. Valentin-Vega YA, Maclean KH, Tait-Mulder J, et al. Mitochondrial dysfunction in ataxia-telangiectasia. Blood 2012;119:1490-1500.
47. Pavlides S, Vera I, Gandara R, et al. Warburg meets autophagy: cancerassociated fibroblasts accelerate tumor growth and metastasis via oxidative stress, mitophagy, and aerobic glycolysis. Antioxid Redox Signal 2012;16:1264-1284.
48. Blandini F, Nappi G, Greenamyre JT. Quantitative study of mitochondrial complex I in platelets of parkinsonian patients. Mov Disord 1998;13:11-15.
49. Borregaard N, Herlin T. Energy metabolism of human neutrophils during phagocytosis. J Clin Invest 1982;70:550-557.
50. Maianski NA, Maianski AN, Kuijpers TW, et al. Apoptosis of neutrophils. Acta Haematol 2004;111:56-66.